Naresh Bumma, MD
Naresh Bumma is an Assistant Professor in the Division of Hematology at Ohio State University where he teaches residents and medical students. He received his medical degree from All India Institute of Medical Sciences New Delhi, India followed by residency from Cleveland Clinic Foundation Cleveland, Ohio and fellowship in Hematology/Oncology from Karmanos Cancer Institute Wayne State University Detroit, United States.
Naresh Bumma is a hematologist at The James Cancer Hospital and Solove Research Institute and is specialized in the diagnosis and treatment of plasma cell disorders such as multiple myeloma and amyloidosis. These disorders are intricately intertwined with the immune system and his research focuses on harnessing the power of the human body’s immune system to treat and cure cancer.
Dr. Bumma is a member of several organizations, including the American Society of Hematology, the American College of Physicians, the American Society of Clinical Oncology and the Society for Immunotherapy of Cancer. His role as a clinical investigator is to focus on research in the field of immunotherapy in multiple myeloma and amyloidosis. Dr. Bumma’s research has been recognized nationally and internationally, and he has been the recipient of the ASH Abstract Achievement Award multiple times.
Dr. Bumma’s clinical expertise includes areas like amyloidosis, bone marrow transplantation, multiple myeloma and plasma cell cancers.
Representative Publications:
Daratumumab Proves Safe and Highly Effective in AL Amyloidosis
Neutrophil Lymphocyte Ratio and Duration of Prior Anti-Angiogenic Therapy as Biomarkers in Metastatic RCC Receiving Immune Checkpoint Inhibitor Therapy
Structure, Development, Preclinical and Clinical Efficacy of Blinatumomab in Acute Lymphoblastic Leukemia
The Antiretroviral Efficacy of Highly Active Antiretroviral Therapy and Plasma Nevirapine Concentrations in HIV-TB Co-Infected Indian Patients Receiving Rifampicin Based Antituberculosis Treatment
